Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -94.91-1,170.52-

What is the latest Core EBITDA Growth ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Growth ratio of BROOKS LABORATORIES is -94.91 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-94.91
Mar2022-1,170.52
Mar2021-

How is Core EBITDA Growth of BROOKS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2023 -94.91
Negative
Mar2022 -1170.52
0
Mar2021 0 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Growth ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹279.7 Cr 4% 10.1% 71.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,167.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,645.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹105,890.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,987.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,950.6 Cr 0.4% -5.4% 82.7% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

4%

10.1%

71.6%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses